24 studies found for:    Open Studies | "Polymyositis"
Show Display Options
Rank Status Study
1 Recruiting Acthar in Treatment of Refractory Dermatomyositis and Polymyositis
Conditions: Dermatomyositis;   Polymyositis
Intervention: Drug: Adrenocorticotropic Hormone Gel
2 Recruiting Efficacy and Tolerability of BAF312 in Patients With Polymyositis
Condition: Polymyositis
Interventions: Drug: Placebo;   Drug: BAF312
3 Not yet recruiting Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis
Conditions: Dermatomyositis;   Polymyositis
Interventions: Drug: tocilizumab;   Drug: Placebo
4 Recruiting Dermatomyositis and Polymyositis Registry
Conditions: Dermatomyositis;   Polymyositis
Intervention: Drug: Acthar
5 Unknown  Abatacept Treatment in Polymyositis and Dermatomyositis
Conditions: Polymyositis;   Dermatomyositis
Intervention: Drug: Abatacept
6 Unknown  Efficacy of an Individual Rehabilitation Program in Polymyositis and Dermatomyositis
Conditions: Dermatomyositis;   Polymyositis
Intervention: Other: Active rehabilitation
7 Recruiting Study and Treatment of Inflammatory Muscle Diseases
Conditions: Autoimmune Disease;   Dermatomyositis;   Inclusion Body Myositis;   Myositis;   Polymyositis
Intervention:
8 Recruiting Adult and Juvenile Myositis
Conditions: Dermatomyositis;   Polymyositis;   Idiopathic Inflammatory Myopathy;   Healthy
Intervention:
9 Recruiting Environmental Risk Factors for Myositis in Military Personnel
Conditions: Dermatomyositis;   Adult Polymyositis;   Inclusion Body Myositis;   Myositis
Intervention:
10 Recruiting Diagnostic Accuracy of Whole Body Magnetic Resonance Imaging in Inflammatory Myopathies
Conditions: Myositis;   Polymyositis;   Dermatomyositis;   Myositis, Inclusion Body
Intervention: Procedure: MRI-oriented muscle biopsy
11 Recruiting Investigating Genes in Patients With Polymyositis and Dermatomyositis
Condition: Myositis
Intervention: Procedure: Venepuncture
12 Unknown  A Study to Evaluate the Safety and Efficacy of Apremilast in the Treatment of Skin Disease in Patients With Dermatomyositis
Condition: Dermatomyositis
Intervention: Drug: Apremilast
13 Unknown  Creatine Supplementation in Pediatric Rheumatology
Conditions: Juvenile Systemic Lupus Erythematosus;   Juvenile Dermatomyositis
Interventions: Dietary Supplement: creatine;   Dietary Supplement: placebo (dextrose)
14 Recruiting Topical Sodium Thiosulfate and Fractional Carbon Dioxide Laser in Treating Dermatomyositis Associated Calcinosis
Condition: Dermatomyositis Associated Superficial Calcinosis
Interventions: Device: Fractional Carbon Dioxide (FCO2) Laser (Candela QuadraLase (TM));   Drug: Sodium thiosulfate
15 Recruiting The CARRA Registry
Conditions: Juvenile Idiopathic Arthritis;   Systemic Lupus Erythematosus;   Mixed Connective Tissue Disease;   Juvenile Ankylosing Spondylitis;   Juvenile Dermatomyositis;   Localized Scleroderma;   Systemic Sclerosis;   Vasculitis;   Sarcoid;   Fibromyalgia, Primary;   Auto-inflammatory Disease;   Idiopathic Uveitis Idiopathic
Intervention:
16 Recruiting Study of Families With Twins or Siblings Discordant for Rheumatic Disorders
Conditions: Rheumatic Diseases;   Rheumatoid Arthritis;   Systemic Lupus Erythematosus;   Scleroderma;   Dermatomyositis;   Myositis
Intervention:
17 Unknown  Five-year Actively Controlled Clinical Trial in New Onset Juvenile Dermatomyositis
Condition: Juvenile Dermatomyositis
Interventions: Drug: 3 MPDN pulse + PDN;   Drug: 3 MPDN pulse + PDN + CSA;   Drug: 3 MPDN pulse + PDN + MTX
18 Recruiting Safety and Efficacy of BAF312 in Dermatomyositis
Condition: Active Dermatomyositis
Interventions: Drug: BAF312 0.5 mg;   Drug: BAF312 2 mg;   Drug: BAF312 10 mg;   Drug: Placebo to BAF312
19 Available Compassionate Use Protocol for the Treatment of Autoinflammatory Syndromes
Conditions: Chronic Atypical Neutrophilic Dermatosis With Lipodystrophy and Elevated Temperature (CANDLE);   Juvenile Dermatomyositis (JDM)
Intervention: Drug: Baricitinib
20 Unknown  Immune Response After Human Papillomavirus Vaccination in Patients With Autoimmune Disease
Conditions: Juvenile Idiopathic Arthritis;   Systemic Lupus Erythematosus;   Juvenile Dermatomyositis
Intervention: Drug: Human papilloma virus vaccine (cervarix)

Previous Page Studies Shown (1-20) Next Page (21-24) Show next page of results
Indicates status has not been verified in more than two years